Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) was $4.84 for the day, up 7.08% from the previous closing price of $4.52. In other words, the price has increased by $7.08 from its previous closing price. On the day, 0.8 million shares were traded.
Ratios:
Our analysis of AMLX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.05 and its Current Ratio is at 12.05. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On November 18, 2024, Robert W. Baird Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $3 to $11.
BofA Securities Upgraded its Neutral to Buy on October 23, 2024, whereas the target price for the stock was revised from $4.20 to $10.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 31 ’25 when FRATES JAMES M sold 10,896 shares for $3.47 per share. The transaction valued at 37,806 led to the insider holds 290,988 shares of the business.
Bedrosian Camille L sold 12,425 shares of AMLX for $43,082 on Mar 31 ’25. The Chief Medical Officer now owns 194,375 shares after completing the transaction at $3.47 per share. On Mar 31 ’25, another insider, Mazzariello Gina, who serves as the Chief Legal Officer of the company, sold 9,192 shares for $3.48 each. As a result, the insider received 31,954 and left with 187,969 shares of the company.
Stock Price History:
Over the past 52 weeks, AMLX has reached a high of $7.27, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is 16.83%, while the 200-Day Moving Average is calculated to be 27.14%.
Shares Statistics:
A total of 89.08M shares are outstanding, with a floating share count of 65.31M. Insiders hold about 26.74% of the company’s shares, while institutions hold 76.78% stake in the company.
